학술논문
PDB14 COST-EFFECTIVENESS OF MONO- AND COMBINATION THERAPY WITH PIOGLITAZONE COMPARED TO GLICLAZIDE IN PATIENTS WITH TYPE-2-DIABETES MELLITUS FROM A GERMAN STATUTORY HEALTH CARE PERSPECTIVE
Document Type
Abstract
Author
Source
In Value in Health 2004 7(6):739-739
Subject
Language
ISSN
1098-3015